S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
Ruptured oil pipeline off California approved for repairs
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
Ruptured oil pipeline off California approved for repairs
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
Ruptured oil pipeline off California approved for repairs
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
Ruptured oil pipeline off California approved for repairs
NASDAQ:HTBX

Heat Biologics - HTBX Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
43,600 shs
Average Volume
171,558 shs
Market Capitalization
$61.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HTBX stock logo

About Heat Biologics (NASDAQ:HTBX) Stock

Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

Receive HTBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heat Biologics and its competitors with MarketBeat's FREE daily newsletter.

HTBX Stock News Headlines

See More Headlines

Receive HTBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heat Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HTBX
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$61.05 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Jeffrey Alan Wolf J.D. (Age 59)
    Founder, Chairman, CEO & Pres
    Comp: $1.31M
  • Mr. William L. Ostrander (Age 54)
    CFO & Sec.
    Comp: $371.07k
  • Dr. Justin Stebbing FRCP
    FRCPath, M.A., M.D., Ph.D., Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
  • Colonel George E. Peoples Jr.
    F.A.C.S., FACS, M.D., Chief Medical Advisor
  • Dr. Anthony M. Manning Ph.D. (Age 60)
    Chief Scientific Advisor
  • Dr. Paul W. Tebbey M.B.A.
    Ph.D., Sr. VP of Product Devel. & Portfolio Strategy













HTBX Stock - Frequently Asked Questions

What other stocks do shareholders of Heat Biologics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heat Biologics investors own include Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Vaxart (VXRT), Bionano Genomics (BNGO), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Novan (NOVN) and VBI Vaccines (VBIV).

What is Heat Biologics' stock symbol?

Heat Biologics trades on the NASDAQ under the ticker symbol "HTBX."

How do I buy shares of Heat Biologics?

Shares of HTBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Heat Biologics make?

Heat Biologics (NASDAQ:HTBX) has a market capitalization of $0.00.

How can I contact Heat Biologics?

The official website for the company is www.heatbio.com. The company can be reached via phone at 919 240 7133.

This page (NASDAQ:HTBX) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.